NYSE ARCA | ETF
The fund is an actively-managed exchange-traded fund ("ETF") that seeks to achieve its objective by investing principally in the common stocks ofU. S. and non-U.S. companies interested in influencing public policy through their lobbying activity in WashingtonD. C.
Strategas Asset Management, LLC (the "Adviser") considers lobbying a nontraditional and largely unrecognized factor in company analysis.
It may, from time to time, invest a significant portion of its total assets in securities of companies in certain sectors or located in particular countries or regions outside theU. S.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DVA | DaVita HealthCare Partners Inc | Healthcare | Medical Care Facilities | 2.56% |
| VRSN | VeriSign Inc | Technology | Software - Infrastructure | 2.53% |
| EBAY | eBay Inc | Consumer Cyclical | Internet Retail | 2.51% |
| TER | Teradyne Inc | Technology | Semiconductor Equipment & Materials | 2.50% |
| FSLR | First Solar Inc | Technology | Solar | 2.29% |
| MTCH | Match Group Inc | Communication Services | Internet Content & Information | 2.28% |
| FOXA | Fox Corp Class A | Communication Services | Entertainment | 2.17% |
| HOLX | Hologic Inc | Healthcare | Medical Instruments & Supplies | 2.16% |
| MO | Altria Group | Consumer Defensive | Tobacco | 2.12% |
| OXY | Occidental Petroleum Corporation | Energy | Oil & Gas E&P | 2.11% |
| CIEN | Ciena Corp | Technology | Communication Equipment | 2.01% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.00% |
| PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 2.00% |
| BF-B | Brown-Forman Corporation | Consumer Defensive | Beverages - Wineries & Distilleries | 2.00% |
| SWK | Stanley Black & Decker Inc | Industrials | Tools & Accessories | 1.99% |
| BA | BAE Systems plc | Industrials | Aerospace & Defense | 1.98% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.96% |
| KOG | Kongsberg Gruppen ASA | Industrials | Aerospace & Defense | 1.94% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.92% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.91% |